Sponsor: Usona Institute
The purpose of this research is to study the medical and safety effects of a single dose of an investigational drug called psilocybin compared to a placebo in participants with depression. Each participant will be randomized to receive either a one-time dose of psilocybin or a placebo.
Phase 2 clinical trials are the second step in a typical four-step drug approval process. During this process, the safety and usefulness of the investigational treatment is tested in larger groups of people as the drug moves through the phases. Phase 2 studies can involve up to several hundred volunteers.
Locations: Chicago, Baltimore, New York, Lauderhill, San Francisco, Madison, New Haven, Santa Monica, Berlin.
3 Months Long | 12 Appointments | 2-10 Hours Each
Each appointment is a little different and visit lengths vary, but most appointments last about 2 hours. At these visits, the following activities may occur:
- Physical exams with a medical professional
- Psychological evaluations and answering questions about your depression
- Blood draws and urine samples
Content retrieved from usonaclinicaltrials.org
Now more than ever, we need reliable and honest contemporary knowledge of psychedelics to be globally accessible. We rely on your support to keep us going; support the dissemination of everything psychedelic with a one-time or recurring contribution and become a Uthymia community member today!